Rebrain services provide precise brain targeting for DBS neurosurgery, enhancing patient outcomes in Parkinson’s disease and Essential Tremor treatments

RebrAIn’s news

Back to Resources

MedTech Strategist Features RebrAIn’s Precision Targeting Solutions for Parkinson’s Disease

We are delighted to share that MedTech Strategist has featured RebrAIn in their latest issue.

The article explores how our supervised AI-driven platform, OptimMRI, simplifies precision targeting for Deep Brain Stimulation (DBS) in Parkinson’s Disease. By enhancing accuracy and reducing costs, RebrAIn aims to make DBS procedures faster, safer, and more accessible. Our innovative approach is set to transform neurosurgical practices, offering improved outcomes for patients.

Read more about our advancements and future plans in the full PDF version of the article.

Back to Resources

Our latest public updates

RebrAIn Hosts Inaugural Medical Advisory Board Meeting (MAB)

RebrAIn Hosts Inaugural Medical Advisory Board Meeting (MAB)

Oct 1, 2024

RebrAIn recently held the inaugural meeting of its Medical Advisory Board (MAB), marking a significant milestone in the company’s ongoing mission to deliver transformative AI-powered tools to neurosurgeons. The meeting also underscored RebrAIn's pivotal role in...